Tilray, Inc. (NASDAQ: TLRY) Q1 2022 earnings call dated Oct. 07, 2021 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D. Simon -- Chairman
Categories
Health Care
Infographic: How Tilray (TLRY) performed in Q1 2022
Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43% year-over-year to
IPO news: Cingulate is making its market debut this week, here’s what to know
The biopharmaceuticals market was valued at approx. $325.17 billion in 2020 and it is expected to grow at a CAGR of 7.3%
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2022 earnings call dated Sep. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
IPO News: What to look for when Healthcare Triangle goes public
The global healthcare information technology market was valued at $74.2 billion in 2020, and it is expected to grow at a compound
iFIT Health & Fitness to raise $600 mln in IPO. Here’s what you need to know
The technology and healthcare industries have dominated the IPO market in the recent past, but it seems the spotlight is shifting to
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
IPO News: Here are a few things to note when Dice Therapeutics goes public
Many pharma companies are lining up to go public and this week will see Dice Therapeutics join the group. The California-based firm,
Avalo Therapeutics CEO Mike Cola on product pipeline and market potential
Credit:DavidBGray on iStock What’s the significance of the name change and why now? Mike: The why now is because we have really
BeyondSpring Inc (BYSI) Q2 2021 Earnings Call Transcript
BeyondSpring Inc (NASDAQ:BYSI) Q2 2021 earnings call dated Sep. 10, 2021. Corporate Participants: Monique Kosse -- Investor Relations Lan Huang -- Co-founder, Chairman & Chief Executive
Avid Bioservices Inc (CDMO) Q1 2021 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 08, 2021. Corporate Participants: Tim Brons -- Avid's Investor Relations Group Nicholas
HealthEquity Inc (HQY) Q2 2022 Earnings Call Transcript
HealthEquity Inc (NASDAQ: HQY) Q2 2022 earnings call dated Sep. 08, 2021. Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President
Affimed NV (AFMD) Q2 2021 Earnings Call Transcript
Affimed NV (NASDAQ: AFMD) Q2 2021 earnings call dated Sep. 08, 2021 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi
IPO Alert: COVID-19 test maker Cue Health is all set to go public
Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading the rally.
Veeva Systems inc (VEEV) Q2 2022 Earnings Call Transcript
Veeva Systems Inc. (NYSE: VEEV) Q2 2022 earnings call dated Sep. 01, 2021 Corporate Participants: Ato Garrett -- Investor Relations Peter Gassner -- Founder and Chief
111 Inc (YI) Q2 2021 Earnings Call Transcript
111 Inc (NASDAQ: YI) Q2 2021 earnings call dated Aug. 27, 2021. Corporate Participants: Monica Mu -- Investor Relations Director Liu Junling
Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript
Catalent, inc (NYSE: CTLT) Q4 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Paul Surdez -- Vice President of Investor Relations John Chiminski -- Chair
Medicure Inc (MPH) Q2 2021 Earnings Call Transcript
Medicure Inc (CVE:MPH) Q2 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Albert D. Friesen -- Chief Executive Officer and Chairman
Predictmedix COO Rahul Kushwah: We aim to be a major player in workplace safety
Courtesy: Predictmedix What’s so special about your safe entry station and what’s the market potential? Rahul: At Predictmedix, our focus is all
Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript
Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive Officer and
Ramsay Health Care Ltd (RHC) Q4 2021 Earnings Call Transcript
Ramsay Health Care Ltd (ASX:RHC) Q4 2021 earnings call dated Aug. 25, 2021. Corporate Participants: Craig McNally -- Managing Director and Chief